Showing results (111-120 of 217) with videos related to
Sort By:
Pageof 22
Learning Health Systems|June 28, 2019
The Global academic research organization network: Data sharing to cure diseases and enable learning health systemsMasanori Fukushima, Christopher Austin, Norihiro Sato, et al.Cancer Letters|July 19, 2005
The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectivesWendy B London, Luca Boni, Thorsten Simon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2011
Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group studyJulie R Park, Jeffrey R Scott, Clinton F Stewart, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2010
Phase II randomized comparison of topotecan plus cyclophosphamide versus topotecan alone in children with recurrent or refractory neuroblastoma: a Children's Oncology Group studyWendy B London, Christopher N Frantz, Laura A Campbell, et al.Oncogene|January 23, 2004
MYCN-mediated regulation of the MRP1 promoter in human neuroblastomaChitra F Manohar, James A Bray, Helen R Salwen, et al.Cancer Research Communications|August 5, 2024
Characterizing Relationships between T-cell Inflammation and Outcomes in Patients with High-Risk Neuroblastoma According to Mesenchymal and Adrenergic SignaturesMaria E Kaufman, Omar R Vayani, Kelley Moore, et al.JCO Global Oncology|February 14, 2022
Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global StageAjay Major, Monica Palese, Ebru Ermis, et al.Cancer Research|December 25, 2002
SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesisAlexandre Chlenski, Shuqing Liu, Susan E Crawford, et al.Cancer Research|March 3, 2006
The MYCN enigma: significance of MYCN expression in neuroblastomaXao X Tang, Huaqing Zhao, Bing Kung, et al.Pediatric Blood & Cancer|September 17, 2013
Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group projectYaël P Mossé, Rebecca J Deyell, Frank Berthold, et al.Pageof 22